Key Events This Week
09 Feb: Q3 FY26 results reveal revenue decline and margin erosion
10 Feb: Downgrade to Strong Sell amid weak fundamentals and bearish technicals
13 Feb: Stock closes at Rs.14.31, down 3.83% on the day
Mar 23
BSE+NSE Vol: 51.82 k

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 20 March 2026, reflecting deteriorating technical indicators, stagnant financial performance, and persistent valuation concerns. The micro-cap healthcare services company’s Mojo Score has declined to 26.0, signalling heightened risk for investors amid ongoing underperformance relative to benchmarks and peers.
Read full news article
Despite a broadly positive market environment, Tejnaksh Healthcare Ltd has slipped to a fresh 52-week low of Rs 12 on 20 Mar 2026, extending its recent downward trajectory amid persistent underperformance and valuation concerns.
Read full news article
Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 March 2026, driven primarily by a shift in technical indicators. Despite this improvement, the healthcare services micro-cap continues to face challenges in financial performance and long-term fundamentals, underscoring a cautious outlook for investors.
Read full news article
Tejnaksh Healthcare Ltd’s shares touched a fresh 52-week low of Rs.12.1 today, marking a significant milestone in the stock’s ongoing decline. The healthcare services company has seen its share price fall sharply over the past year, reflecting persistent challenges in its financial performance and market positioning.
Read full news article
09 Feb: Q3 FY26 results reveal revenue decline and margin erosion
10 Feb: Downgrade to Strong Sell amid weak fundamentals and bearish technicals
13 Feb: Stock closes at Rs.14.31, down 3.83% on the day

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 9 February 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite a very attractive valuation, the company’s flat financial performance, declining profitability, and bearish technical trends have prompted a reassessment of its outlook within the Healthcare Services sector.
Read full news articleTejnaksh Healthcare Ltd's latest financial results indicate significant challenges in its operational performance. For the quarter ended December 2025, the company reported consolidated net sales of ₹2.62 crores, reflecting a year-on-year decline of 17.87%. This marks the third consecutive quarter of revenue contraction, with previous quarters also showing declines of 15.38% and 11.57%. The persistent decrease in sales suggests underlying structural issues rather than temporary fluctuations. The company's consolidated net profit for the same period was ₹0.30 crores, which represents a substantial year-on-year decline of 50.82%. This decline in profitability is accompanied by a decrease in the profit after tax margin, which fell to 11.07% from 17.55% in the previous year. The operating margin also experienced compression, dropping to 26.34%, down from 35.42% in the prior year, indicating significant operati...
Read full news article
Tejnaksh Healthcare Ltd., a Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.30 crores for Q3 FY26, marking a sharp 50.82% decline year-on-year from ₹0.61 crores in Q3 FY25. The micro-cap company, with a market capitalisation of ₹32.00 crores, witnessed its third consecutive quarter of revenue contraction, raising concerns about operational sustainability in an otherwise resilient healthcare services sector.
Read full news articlePlease refer standalone and consolidated unaudited result for the quarter ended 31st December 2025.
In continuation of our Letter dated 2th February 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday 7th February 2026 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound Block Sector: Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060 to at 4.00 pm. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31th December 2025 and took note of Limited Review Report thereon in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; The meeting of Board of Directors commenced at 4:00 pm and concluded at 6.00 pm This is for your information and record.
Respected Sir/Madam Please refer letter attached for your reference. Thanks Afrin Shaikh
No Upcoming Board Meetings
No Dividend history available
Tejnaksh Healthcare Ltd has announced 5:10 stock split, ex-date: 19 Jul 23
Tejnaksh Healthcare Ltd has announced 36:10 bonus issue, ex-date: 26 Apr 18
No Rights history available